Skip to main content
Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
38.15
+0.30 (0.79%)
Apr 25, 2025, 10:37 AM CET

Dermapharm Holding SE Revenue

In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B EUR with 3.89% growth. Dermapharm Holding SE had revenue of 295.67M in the quarter ending December 31, 2024, with 7.85% growth.

Revenue
1.20B
Revenue Growth
+3.89%
P/S Ratio
1.70
Revenue / Employee
331.15K
Employees
3,610
Market Cap
2.04B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.20B44.72M3.89%
Dec 31, 20231.15B110.19M10.59%
Dec 31, 20221.04B80.46M8.38%
Dec 31, 2021960.09M151.78M18.78%
Dec 31, 2020808.31M93.94M13.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.44B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Dermapharm Holding SE News

More News